The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122675056 12267505 6 F 20160311 20160728 20160414 20160804 PER PHEH2016US008491 NOVARTIS 52.47 YR F Y 90.00000 KG 20160805 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122675056 12267505 1 PS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Oral 0.5 MG, QD 1644 MG 22527 .5 MG CAPSULE QD
122675056 12267505 2 SS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Unknown UNK, QOD 1644 MG 22527 CAPSULE
122675056 12267505 3 C CHANTIX VARENICLINE TARTRATE 1 Unknown U 0
122675056 12267505 4 C OXCARBAZEPINE. OXCARBAZEPINE 1 Unknown 2 DF, BID U 0 2 DF BID
122675056 12267505 5 C OXYCODONE OXYCODONE 1 Unknown UNK UNK, QW U 0 /wk
122675056 12267505 6 C GRALISE GABAPENTIN 1 Unknown 3 DF, AT BEDTIME U 0 3 DF
122675056 12267505 7 C CLONAZEPAM. CLONAZEPAM 1 Unknown 2 DF, AT BEDTIME U 0 2 DF
122675056 12267505 8 C METOPROLOL. METOPROLOL 1 Unknown 1 DF, QD U 0 1 DF QD
122675056 12267505 9 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Unknown 1 DF, QD U 0 1 DF QD
122675056 12267505 10 C TIZANIDINE HCL TIZANIDINE HYDROCHLORIDE 1 Unknown 1 DF, TID U 0 1 DF TID
122675056 12267505 11 C TOPIRAMATE. TOPIRAMATE 1 Unknown 1 IN MORNING AND 2 AT BEDTIME U 0 3 DF
122675056 12267505 12 C BACLOFEN. BACLOFEN 1 Unknown 1 DF, QID U 0 1 DF QID
122675056 12267505 13 C AMBIEN CR ZOLPIDEM TARTRATE 1 Unknown 1 DF, AT BEDTIME U 0 1 DF
122675056 12267505 14 C AMFETAMINE AMPHETAMINE 1 Unknown (1 IN THE MORNING AND 1 AT NOON TIME) U 0 2 DF
122675056 12267505 15 C DONEPEZIL. DONEPEZIL 1 Unknown 1 DF, QD U 0 1 DF QD
122675056 12267505 16 C CRESTOR ROSUVASTATIN CALCIUM 1 Unknown 20 MG, (AT BEDTIME) U 0 20 MG
122675056 12267505 17 C FUROSEMIDE. FUROSEMIDE 1 Unknown 1 DF, PRN U 0 1 DF
122675056 12267505 18 C FOLIC ACID. FOLIC ACID 1 Unknown 1 DF, QD U 0 1 DF QD
122675056 12267505 19 C PROMETHAZINE PROMETHAZINEPROMETHAZINE HYDROCHLORIDE 1 Unknown 1 DF, Q6H U 0 1 DF Q6H
122675056 12267505 20 C KLOR-CON POTASSIUM CHLORIDE 1 Unknown 1 DF, QD U 0 1 DF QD
122675056 12267505 21 C LIDODERM LIDOCAINE 1 Unknown ( EVERY 2 TO 3 DAYS) U 0 PATCH
122675056 12267505 22 C VITAMIN B12 CYANOCOBALAMIN 1 Unknown U 0
122675056 12267505 23 C FISH OIL FISH OIL 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122675056 12267505 1 Multiple sclerosis
122675056 12267505 3 Product used for unknown indication
122675056 12267505 4 Product used for unknown indication
122675056 12267505 5 Pain
122675056 12267505 6 Product used for unknown indication
122675056 12267505 7 Product used for unknown indication
122675056 12267505 8 Product used for unknown indication
122675056 12267505 9 Product used for unknown indication
122675056 12267505 10 Product used for unknown indication
122675056 12267505 11 Product used for unknown indication
122675056 12267505 12 Product used for unknown indication
122675056 12267505 13 Product used for unknown indication
122675056 12267505 14 Product used for unknown indication
122675056 12267505 15 Product used for unknown indication
122675056 12267505 16 Product used for unknown indication
122675056 12267505 17 Product used for unknown indication
122675056 12267505 18 Product used for unknown indication
122675056 12267505 19 Nausea
122675056 12267505 20 Product used for unknown indication
122675056 12267505 21 Product used for unknown indication
122675056 12267505 22 Product used for unknown indication
122675056 12267505 23 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
122675056 12267505 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122675056 12267505 Balance disorder
122675056 12267505 Blood glucose increased
122675056 12267505 Carbon dioxide decreased
122675056 12267505 Diplopia
122675056 12267505 Erythema
122675056 12267505 Lacrimation decreased
122675056 12267505 Lepromatous leprosy
122675056 12267505 Leprosy
122675056 12267505 Lymphocyte count decreased
122675056 12267505 Mean platelet volume increased
122675056 12267505 Multiple sclerosis
122675056 12267505 Muscular weakness
122675056 12267505 Nodule
122675056 12267505 Prescribed underdose
122675056 12267505 Rash
122675056 12267505 Type 2 lepra reaction
122675056 12267505 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122675056 12267505 1 201112 20160406 0